Eisai Co., Ltd. announced today that it has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride…
Biogen (Nasdaq: BIIB) and Neurimmune announced today that Biogen has exercised its option to further reduce the previously negotiated royalty rates payable on potential future sales…View More BIOGEN AND NEURIMMUNE ANNOUNCE OPTION EXERCISE FOR ALZHEIMER’S DISEASE INVESTIGATIONAL TREATMENT ADUCANUMAB
Abbott is communicating to physicians about a field corrective action related to the HeartMate 3™ Left Ventricular Assist Device (LVAD). Abbott notified physicians and global regulatory…View More ABBOTT IMPLEMENTS CORRECTIVE ACTION FOR HEARTMATE 3 HEART PUMP
Eli Lilly and Company (NYSE: LLY) and Indiana University’s Richard M. Fairbanks School of Public Health at IUPUI announced today the launch of a new neighborhood-based, data-driven pilot…View More Lilly and Local Partners Launch Diabetes Prevention and Management Pilot in Three Undeserved Neighborhoods in Indianapolis.
Johnson & Johnson (NYSE: JNJ) will participate in the 2018 UBS Global Health Care Conference on Monday, May 21st, at the Grand Hyatt, New York.…View More Johnson & Johnson to Participate in the 2018 UBS Global Health Care Conference